@article{606ba6269da2414ebe558259cc1e7473,
title = "Personality disorders among Spanish prisoners starting hepatitis C treatment: Prevalence and associated factors",
abstract = "The purpose of this study was to assess the prevalence of personality disorders (PDs) and their associated factors in prisoners who initiate chronic hepatitis C (CHC) treatment in 25 Spanish prisons. The Personality Diagnostic Questionnaire-4 was used to diagnose PDs according to DSM-IV criteria. Factors potentially associated with a PD diagnosis were evaluated by logistic regression analysis. Two hundred and fifty-five patients were initially assessed and 62 (24.3%) were excluded due to an incomplete or invalid self-report screening questionnaire. PD prevalence was 70.5%, with antisocial PD being the most prevalent (46.1%). In terms of PD clusters, the most prevalent was cluster-B (55.4%). PD diagnosis was associated with HCV genotypes 1, 2, or 3 (odds ratio [OR] 2.14, 95% confidence interval [CI] 1.02-4.49). Patients with a cluster-B PD were more likely to be infected with HCV genotypes 1, 2, or 3 (OR 2.37, 95% CI 1.08-5.23) and be HIV-infected (OR 2.20, 95% CI 1.10-4.39), to report past-year injection drug use (OR 7.17, 95% CI 1.49-34.58), and to have stage 3 or 4 fibrosis (OR 2.16, 95% CI 1.06-4.49). The prevalence of PDs in Spanish prisoners who initiate CHC treatment is very high. PD management issues should be considered in treating CHC patients in prisons.",
keywords = "Chronic hepatitis C, Epidemiology, Personality Disorder Questionnaire-4 (PDQ-4), Personality disorder, Prevalence, Prisons",
author = "{the PERSEO Group} and Andr{\'e}s Marco and Ant{\'o}n, {Jos{\'e} J.} and {Saiz de la Hoya}, Pablo and {de Juan}, Jos{\'e} and Inmaculada Faraco and Cayl{\`a}, {Joan A.} and Joan Trujols and C. Alia and G. Almada and F. Amaya and Antol{\'i}n, {J. M.} and M. Bedia and J. Borrego and E. Campo and {da Silva}, A. and D{\'i}az, {J. R.} and J. Domingo and V. Ferrer and C. Gallego and J. Garc{\'i}a-Guerrero and C. Guti{\'e}rrez and Herrero, {A. M.} and C. Hoyos and G. Jim{\'e}nez-Gal{\'a}n and Laine, {J. M.} and E. Leandro and C. L{\'o}pez and R. Muros and F. Paniagua and {P{\'e}rez delosCobos}, J. and A. P{\'e}rez-Va-lenzuela and R. Planella and E. Pozo and Rebolledo, {J. R.} and F. Ru{\'i}z and P. S{\'a}nchez-Arrobas and C. Sarriera and C. Sol{\'e} and Vasallo, {L. C.} and M. Veiras and C. Yllobre and J. Z{\'u}{\~n}iga",
note = "Funding Information: The Infectious Diseases Working Group of the Spanish Society of Prison Health (Grupo de Enfermedades Infecciosas de la Sociedad Espa{\~n}ola de Sanidad Penitenciaria; GEISESP) was the sponsor of the study through an unrestricted research grant from Roche Farma, S.A. GEISESP was involved in the design and conduct of the study, and the preparation, review and approval of the manuscript. Roche Farma, S.A. has funded study monitoring and data analysis and had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the paper for publication. Publisher Copyright: {\textcopyright} 2015 Elsevier Ireland Ltd.",
year = "2015",
month = may,
day = "3",
doi = "10.1016/j.psychres.2015.11.016",
language = "English (US)",
volume = "230",
pages = "749--756",
journal = "Psychiatry research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "3",
}